</head> <body style="-ms-text-size-adjust:100%;-webkit-text-size-adjust:100%;margin:0;min-width:100%;padding:0;width:100%" data-bg-color="#E9EBF2" bgcolor="#E9EBF2">
CB Partner Webinar {{webinarsautomatedemailsregistrationconfirmation::webinar_duration}} VDI Laboratory {{webinarsautomatedemailsregistrationconfirmation::client_only_logo}} {{webinarsautomatedemailsregistrationconfirmation::client_only_logo_self_hosted}} {{webinarsautomatedemailsregistrationconfirmation::client_only_logo_alt}} {{webinarsautomatedemailsregistrationconfirmation::client_only_logo_width}} {{webinarsautomatedemailsregistrationconfirmation::client_only_logo_custom_css}} {{webinarsautomatedemailsregistrationconfirmation::client_color}} {{webinarsautomatedemailsregistrationconfirmation::supported_by}} This webinar will review sources and applications of biomarkers, describe the role of biomarker tests being marketed, and focus on the role of TK1 in detecting cancer and other diseases. Biomarkers are substances derived from bodily fluids that reflect the state of health or disease in an individual. When used in combination with physical and other clinicopathologic findings, biomarkers can guide therapy or additional diagnostic testing. Thymidine kinase 1 (TK1) is a soluble marker of proliferation that can be easily measured in the blood and reflect an occult or suspected diagnosis of cancer. Combining 2 or more biomarkers is usually more powerful than considering only the changes in a single biomarker. {{webinarsautomatedemailsregistrationconfirmation::learning_objectives_bullet_5}} {{webinarsautomatedemailsregistrationconfirmation::learning_objectives_bullet_6}}
Dear #FIRSTNAME#,
Thank you for registering for "#EVENTTITLE#," sponsored by VDI Laboratory. Thank you for registering for "#EVENTTITLE#."
This webinar will review sources and applications of biomarkers, describe the role of biomarker tests being marketed, and focus on the role of TK1 in detecting cancer and other diseases.
If you have any questions for our speaker, you can direct them to support@cliniciansbriefhelp.zendesk.com
Learning Objectives
  • Biomarkers are substances derived from bodily fluids that reflect the state of health or disease in an individual.
  • When used in combination with physical and other clinicopathologic findings, biomarkers can guide therapy or additional diagnostic testing.
  • Thymidine kinase 1 (TK1) is a soluble marker of proliferation that can be easily measured in the blood and reflect an occult or suspected diagnosis of cancer.
  • Combining 2 or more biomarkers is usually more powerful than considering only the changes in a single biomarker.
If you have any questions for our speaker, you can direct them to support@cliniciansbriefhelp.zendesk.com
Webinar Details
#EVENTDAY#, #EVENTDATE#  |  #EVENTTIME# #EVENTTIMEZONESHORT#  |  {{webinarsautomatedemailsregistrationconfirmation::webinar_duration}}
Sponsored by VDI Laboratory
Add to Your Calendar
Use the links below to add to your calendar. We'll also send a couple reminders in advance of the webinar.
#CALENDARREMINDER#
How to Join the Webinar
Click the link below to join the webinar. You can join up to 15 minutes before the start time.
#AUDIENCEURL#
Once you click the link, you may be prompted to sign in with the email you used to register (#EMAIL#).
Thank you for registering! We look forward to seeing you.
Sincerely,
The Clinician's Brief Team
The VDI Laboratory Team
</head> <body style="-ms-text-size-adjust:100%;-webkit-text-size-adjust:100%;margin:0;min-width:100%;padding:0;width:100%" data-bg-color="#E9EBF2" bgcolor="#E9EBF2">
Dear #FIRSTNAME#,
Thank you for registering for "#EVENTTITLE#," sponsored by VDI Laboratory. Thank you for registering for "#EVENTTITLE#."
This webinar will review sources and applications of biomarkers, describe the role of biomarker tests being marketed, and focus on the role of TK1 in detecting cancer and other diseases.
If you have any questions for our speaker, you can direct them to support@cliniciansbriefhelp.zendesk.com
Learning Objectives
  • Biomarkers are substances derived from bodily fluids that reflect the state of health or disease in an individual.
  • When used in combination with physical and other clinicopathologic findings, biomarkers can guide therapy or additional diagnostic testing.
  • Thymidine kinase 1 (TK1) is a soluble marker of proliferation that can be easily measured in the blood and reflect an occult or suspected diagnosis of cancer.
  • Combining 2 or more biomarkers is usually more powerful than considering only the changes in a single biomarker.
If you have any questions for our speaker, you can direct them to support@cliniciansbriefhelp.zendesk.com
Webinar Details
#EVENTDAY#, #EVENTDATE#  |  #EVENTTIME# #EVENTTIMEZONESHORT#  |  {{webinarsautomatedemailsregistrationconfirmation::webinar_duration}}
Sponsored by VDI Laboratory
Add to Your Calendar
Use the links below to add to your calendar. We'll also send a couple reminders in advance of the webinar.
#CALENDARREMINDER#
How to Join the Webinar
Click the link below to join the webinar. You can join up to 15 minutes before the start time.
#AUDIENCEURL#
Once you click the link, you may be prompted to sign in with the email you used to register (#EMAIL#).
Thank you for registering! We look forward to seeing you.
Sincerely,
The Clinician's Brief Team
The VDI Laboratory Team